About NeuMoDx
NeuMoDx is a company based in Ann Arbor (United States) founded in 2012 was acquired by Qiagen in September 2020.. NeuMoDx has raised $66.04 million across 5 funding rounds from investors including Qiagen, Baird Capital and Venture Investors. The company has 125 employees as of December 31, 2022. NeuMoDx operates in a competitive market with competitors including DermTech, GenMark Diagnostics, Biocartis, Biomeme and Molbio Diagnostics, among others.
- Headquarter Ann Arbor, United States
- Employees 125 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Neumodx Molecular, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Software Development Team
67 people
Leadership Team
56 people
Sales and Marketing
55 people
Senior Team
47 people
Human Resources and Administration
29 people
Operations Team
17 people
Product Management Team
16 people
Field Team
14 people
Unlock access to complete
Funding Insights of NeuMoDx
NeuMoDx has successfully raised a total of $66.04M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $20.04 million completed in April 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $20.0M
-
First Round
First Round
(09 Apr 2012)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2018 | Amount | Series B - NeuMoDx | Valuation |
investors |
|
| Mar, 2018 | Amount | Debt – Conventional - NeuMoDx | Valuation |
investors |
|
| Apr, 2016 | Amount | Series B - NeuMoDx | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NeuMoDx
NeuMoDx has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Qiagen, Baird Capital and Venture Investors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity and venture capital investments in B2B Tech & Services companies.
|
Founded Year | Domain | Location | |
|
Multiple sectors focused seed & early stage VC firm investing in the US, Europe & Asia
|
Founded Year | Domain | Location | |
|
Healthcare venture capital investments are made by Arboretum Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NeuMoDx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NeuMoDx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neumodx Comparisons
Competitors of NeuMoDx
NeuMoDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DermTech, GenMark Diagnostics, Biocartis, Biomeme and Molbio Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Adhesive patch biopsies for skin cancer detection are provided.
|
|
| domain | founded_year | HQ Location |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| domain | founded_year | HQ Location |
Molecular assays for disease detection are developed using proprietary technology.
|
|
| domain | founded_year | HQ Location |
Smartphone-based DNA detection platform is developed for diagnostics.
|
|
| domain | founded_year | HQ Location |
Point-of-care molecular platforms for infectious disease detection are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Neumodx
Frequently Asked Questions about NeuMoDx
When was NeuMoDx founded?
NeuMoDx was founded in 2012.
Where is NeuMoDx located?
NeuMoDx is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Is NeuMoDx a funded company?
NeuMoDx is a funded company, having raised a total of $66.04M across 5 funding rounds to date. The company's 1st funding round was a Series B of $20M, raised on Apr 09, 2012.
How many employees does NeuMoDx have?
As of Dec 31, 2022, the latest employee count at NeuMoDx is 125.
What does NeuMoDx do?
NeuMoDx was founded in 2012 and is located in Ann Arbor, United States. A patent-pending platform for molecular testing is developed, focusing on the diagnostics sector. Magnetic particle affinity capture and real-time PCR chemistry are combined in a multi-sample microfluidic cartridge. The lead product, NeuMoDx 500, is utilized as a fully automated, random-access in vitro diagnostic system for RNA and DNA-based assays.
Who are the top competitors of NeuMoDx?
NeuMoDx's top competitors include DermTech, GenMark Diagnostics and Biocartis.
Who are NeuMoDx's investors?
NeuMoDx has 6 investors. Key investors include Qiagen, Baird Capital, Venture Investors, Arboretum Ventures, and Pfizer Venture Investments.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.